Gritstone bio falls after filing for bankruptcy

Gritstone bio

10/10/2024 11:02

** Shares of drug developer Gritstone bio  GRTS.O  fall
29.4% to 14 cents premarket
    ** Company files for Chapter 11 bankruptcy
    ** GRTS lists both estimated assets and liabilities at $100
million to $500 million - court filing
    ** "During its financial restructuring process, Gritstone
intends to operate in the ordinary course and remains committed
to advancing its clinical programs" - company
    ** Up to last close, stock down 90.3% YTD

 (Reporting by Puyaan Singh)
 ((Puyaan.Singh@thomsonreuters.com;))